A business in context
IONS research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-31 | BENNETT C FRANK | J · Other (see filing) | Common Stock | 110.0 | 51.31 |
| 2026-08-31 | O'NEIL PATRICK R. | J · Other (see filing) | Common Stock | 63.0 | 51.31 |
| 2026-08-31 | Monia Brett P | J · Other (see filing) | Common Stock | 98.0 | 51.31 |
| 2026-08-31 | Birchler Brian | J · Other (see filing) | Common Stock | 58.0 | 51.31 |
| 2026-07-31 | Hayden Michael R | P · Purchase | Common Stock | 5000.0 | 51.6 |
| 2026-07-30 | Hayden Michael R | P · Purchase | Common Stock | 15000.0 | 53.38 |
| 2026-07-15 | Reikes Peter N | A · Grant / award | Restricted Stock Unit | 3399.0 | 0.0 |
| 2026-07-15 | HANTSON LUDWIG | A · Grant / award | Restricted Stock Unit | 3399.0 | 0.0 |
| 2026-07-15 | HERMAN JOAN E | M · Exercise / conversion | Common Stock | 5220.0 | 0.0 |
| 2026-07-15 | HERMAN JOAN E | M · Exercise / conversion | Restricted Stock Unit | 5220.0 | 0.0 |
| 2026-07-15 | BERTHELSEN SPENCER R | M · Exercise / conversion | Common Stock | 5220.0 | 0.0 |
| 2026-07-15 | BERTHELSEN SPENCER R | M · Exercise / conversion | Restricted Stock Unit | 5220.0 | 0.0 |
| 2026-07-07 | BENNETT C FRANK | S · Sale | Common Stock | 15000.0 | 85.46 |
| 2026-07-07 | BENNETT C FRANK | S · Sale | Common Stock | 5536.0 | 83.58 |
| 2026-07-07 | BENNETT C FRANK | J · Other (see filing) | Common Stock | 15000.0 | 0.0 |
| 2026-07-07 | BENNETT C FRANK | J · Other (see filing) | Restricted Stock Unit | 15000.0 | 0.0 |
| 2026-07-07 | Diaz Allene M. | S · Sale | Common Stock | 10111.0 | 85.42 |
| 2026-07-07 | Diaz Allene M. | M · Exercise / conversion | Common Stock | 10111.0 | 47.11 |
| 2026-07-07 | Diaz Allene M. | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 10111.0 | 0.0 |
| 2026-07-07 | Kordasiewicz Holly B. | S · Sale | Common Stock | 362.0 | 84.3 |
| 2026-07-01 | YANG MICHAEL J. | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | YANG MICHAEL J. | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
| 2026-07-01 | LOSCALZO JOSEPH | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | LOSCALZO JOSEPH | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
| 2026-07-01 | HERMAN JOAN E | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
| 2026-07-01 | HERMAN JOAN E | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | KLEIN JOSEPH III | M · Exercise / conversion | Common Stock | 11518.0 | 39.94 |
| 2026-07-01 | KLEIN JOSEPH III | S · Sale | Common Stock | 99.0 | 79.45 |
| 2026-07-01 | KLEIN JOSEPH III | S · Sale | Common Stock | 11419.0 | 79.04 |
| 2026-07-01 | KLEIN JOSEPH III | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | KLEIN JOSEPH III | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
| 2026-07-01 | KLEIN JOSEPH III | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 11518.0 | 0.0 |
| 2026-07-01 | Hayden Michael R | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | Hayden Michael R | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
| 2026-07-01 | Diaz Allene M. | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | Diaz Allene M. | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
| 2026-07-01 | BERTHELSEN SPENCER R | A · Grant / award | Non-Qualified Stock Option (right to buy) | 5369.0 | 0.0 |
| 2026-07-01 | BERTHELSEN SPENCER R | A · Grant / award | Restricted Stock Unit | 2301.0 | 0.0 |
Identity & relationships
SEC issuer · 0000874015IONIS PHARMACEUTICALS INC
Search names and former names
- ISIS PHARMACEUTICALS INC · former SEC name · 1996-06-12 to 2015-12-18
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $705.14M | $757.38M |
| 2023-12-31 | $787.65M | $870.93M |
| 2022-12-31 | $587.37M | $676.14M |
| 2021-12-31 | $810.46M | $1.01B |
| 2020-12-31 | $729.26M | $949.40M |
| 2019-12-31 | $1.12B | $1.48B |
| 2018-12-31 | $599.67M | $804.62M |
| 2017-12-31 | $514.18M | $706.77M |